Furthermore, a study focusing on acute myeloid leukemia (AML) has indicated that, in AML patients, there is a significant decrease in the proportion of monocytes, while LRRC25 exhibits high expression in primary bone marrow cells (granulocytes and monocytes) but low expression in lymphocytes. Here, LRRC25 is linked to acute myeloid leukemia.